查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2129002

標靶蛋白分解市場：依產品類型、開發階段、應用、最終用戶、國家及地區分類－產業分析、市場規模、市場佔有率及2026-2033年預測

Targeted Protein Degradation Market, By Product Type, By Development Stage, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，標靶蛋白質分解 (TPD) 市場價值將達到 7.038 億美元，從 2026 年到 2033 年將以 21.2% 的複合年成長率成長。

標靶蛋白分解（TPD）是指利用細胞自身天然的蛋白質分解途徑，特異性清除致病或與疾病相關的蛋白，進而開發、推廣和應用治療技術。 TPD技術旨在透過誘導目標蛋白泛素化，然後利用蛋白酶體和其他細胞內分解過程將其分解，最終從細胞中清除目標蛋白。

標靶蛋白分解市場－市場動態

針對疾病相關蛋白的新療法的需求不斷成長，以及針對 TPD 的藥物的研發，預計將推動市場需求。

對新型藥物療法的需求日益成長，以應對各種複雜的目標蛋白，這推動了靶向蛋白水解市場的發展。傳統的小分子抑制劑通常需要標靶蛋白上合適的結合位點才能發揮治療作用，並且往往依賴維持足夠的標靶蛋白佔有率。而標靶蛋白水解（TPD）並非單純抑制標靶蛋白的功能，而是利用細胞自身的分解機制來清除標靶蛋白。這種獨特的方法使研究人員能夠靶向以往難以成藥的蛋白，並獲得更持久的生物效應。此外，癌症和其他慢性疾病的日益普遍也促使人們尋求新的治療策略。因此，製藥和生物技術公司正在積極進行TPD研究，以期擴大可治療的生物標的範圍，同時克服現有療法的抗藥性和限制。

標靶分解劑（TPD）的開發是一個跨學科過程，它融合了化學生物學、藥物化學、E3連接酶生物學、蛋白質體學、結構生物學、電腦建模和臨床開發等領域的專業知識。隨著該領域日益專業化，策略合作和授權合約對於整合互補技能至關重要。大型製藥企業擁有創新的分解劑平台和特定藥物研發領域的專業知識。例如，C4 Therapeutics公司透過開發TORPEDO平台拓展了蛋白質分解技術的應用範圍。該平台能夠建構多種標靶分解策略，包括分子黏合劑、異雙功能分解劑和分解劑-抗體偶聯物。

標靶蛋白分解市場－市場細分分析：

全球標靶蛋白質分解市場按產品類型、開發階段、應用、最終用戶和地區進行細分。

根據產品類型，市場可分為五大類：PROTAC 類分解劑、LYTAC 類分解劑、分子黏合劑分解劑、AUTOTAC 類分解劑和其他類分解劑。 PROTAC 類分解劑預計將佔據市場銷售額的很大佔有率。 PROTAC 類分解劑可促進標靶蛋白的泛素化，並隨後透過蛋白酶體進行分解。臨床開發，特別是腫瘤領域的開發，正顯著推動該細分市場的成長。由 Arvinas 和輝瑞公司共同開發的 Bepdegestrant 是一種口服 PROTAC 型雌激素受體分解劑，目前正在評估其在 ER 陽性/HER2 陰性晚期癌症中的應用。

標靶蛋白分解 (TPD) 市場—區域分析

憑藉成熟的生物技術和製藥產業、領先的大學研究機構、專業的藥物研發技術以及創業投資資金籌措，北美在靶向蛋白分解（TPD）領域持續佔據主導地位。許多新興生技公司和研究機構，包括Arvinas、C4 Therapeutics、Kymera Therapeutics和Nurix Therapeutics等TPD研發公司，都集中在美國。歐洲擁有成熟的製藥產業、化學生物學和藥物化學的專業知識，並不斷增加對下一代治療技術的投資，已成為TPD研究和創新的重要中心。英國、瑞士、德國、法國和丹麥等國透過藥物研發、學術合作和生物技術活動，為TPD平台的發展做出了貢獻。

目錄

第1章：靶向蛋白分解市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：標靶蛋白質分解的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：標靶蛋白質分解的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 標靶蛋白質分解市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：標靶蛋白質分解的市場趨勢

  • 標靶蛋白質分解市場佔有率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 標靶蛋白分解市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 基於PROTAC的分解器
    • LYTACs
    • 分子黏合劑型分解劑
    • AUTOTACs
    • 其他

第8章 標靶蛋白分解市場：依發展階段分類

  • 概述
    • 細分市場佔有率分析：依發展階段分類
    • 臨床前階段
    • 商業化

第9章 標靶蛋白質分解市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 腫瘤學
    • 骨髓惡性腫瘤
    • 自體免疫/發炎性疾病
    • 心血管疾病
    • 其他

第10章 標靶蛋白質分解市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 製藥和生物技術公司
    • 學術研究
    • CRO
    • 醫院
    • 其他

第11章 標靶蛋白分解市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章：主要供應商分析：標靶蛋白質分解產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Arvinas, Inc.
    • Bristol Myers Squibb
    • C4 Therapeutics, Inc.
    • Kymera Therapeutics, Inc.
    • Nurix Therapeutics, Inc.
    • AstraZeneca plc
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • Bayer AG
    • Monte Rosa Therapeutics
    • Captor Therapeutics
    • Foghorn Therapeutics
    • Biotheryx, Inc.
    • Cullgen, Inc.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7380

Targeted Protein Degradation Market size was valued at USD 703.8 Million in 2025, expanding to a CAGR of 21.2% from 2026 to 2033.

Targeted protein degradation (TPD) refers to the creation, marketing, and use of therapeutic technologies that use the cell's natural protein-degradation pathways to specifically remove disease-causing or disease-associated proteins. By causing target proteins to be ubiquitinated and then broken down by the proteasome or other cellular degradation processes, TPD techniques are intended to extract target proteins from cells.

Targeted Protein Degradation Market- Market Dynamics

Increasing demand for novel therapies for addressing drug proteins and developments in pharmaceutical for TPD are expected to propel market demand

Increasing demand for novel drug therapies for addressing various complex drug proteins is fueling targeted protein degradation market growth. In order to have a therapeutic impact, conventional small-molecule inhibitors usually need a suitable binding site on the target protein and frequently rely on maintaining enough target occupancy. Instead of merely inhibiting the target protein's function, targeted protein degradation (TPD) uses the cell's natural degradation mechanism to eliminate the target protein itself. Researchers may be able to target previously difficult-to-drug proteins and possibly accomplish more long-lasting biological effects thanks to this unique approach. Furthermore, the need for novel therapeutic strategies is growing as the prevalence of cancer and other chronic illnesses rises. Therefore, TPD is being investigated by pharmaceutical and biotech companies as a way to extend the variety of biological targets that may be therapeutically addressed while overcoming treatment resistance and constraints associated with current therapies.

Expertise in chemical biology, medicinal chemistry, E3 ligase biology, proteomics, structural biology, computer modelling, and clinical development are all combined in the multidisciplinary process of TPD development. Strategic alliances and license agreements are now crucial for integrating complementing skills as the profession grows more specialized. Innovative degrader platforms and specific drug discovery expertise are available to large pharmaceutical corporations. For instance, C4 Therapeutics has expanded the possible uses of its protein-degradation technology by developing its TORPEDO platform, which facilitates the creation of several targeted degradation strategies, such as molecular glues, heterobifunctional degraders, and degrader-antibody conjugates.

Targeted Protein Degradation Market- Segmentation Analysis:

The Global Targeted Protein Degradation Market is segmented on the basis of Product Type, Development Stage, Application, End User, and Region.

The market is divided into five categories based on Product Type: PROTAC-based degraders, LYTACs, molecular glue degraders, AUTOTACs, and others. PROTAC-based degraders segment is estimated to hold a large revenue share in the market. PROTACs promote ubiquitination and subsequent proteasomal degradation of the target. The segment growth is substantially boosted by clinical development, particularly in oncology. Vepdegestrant, developed by Arvinas and Pfizer, is an orally bioavailable PROTAC estrogen receptor degrader being evaluated for ER+/HER2- advanced.

Targeted Protein Degradation Market- Geographical Insights

With its well-established biotechnology and pharmaceutical industries, top university research institutions, specialized drug-discovery skills, and access to venture capital funding, North America continues to have a dominant position in the targeted protein degradation industry. TPD developers, such as Arvinas, C4 Therapeutics, Kymera Therapeutics, and Nurix Therapeutics, as well as many new biotechnology firms and research institutions, are concentrated in the United States in particular. With its well-established pharmaceutical industry, knowledge of chemical biology and medicinal chemistry, and growing investment in next-generation therapeutic technologies, Europe is a significant centre for TPD research and innovation. Through pharmaceutical research, academic partnerships, and biotechnology activities, nations including the UK, Switzerland, Germany, France, and Denmark are helping to build TPD platforms.

China Targeted Protein Degradation Market- Key Insights

China, with its rapidly growing biotechnology sector, pharmaceutical R&D capabilities, and precision-medicine environment, has the potential to be a significant market for targeted protein degradation. PROTACs, molecular glues, and other targeted degradation technologies are being developed by a rising number of local biotechnology and pharmaceutical businesses, with research progressing from early-stage discovery into preclinical and clinical development. In addition to immune-related and other chronic diseases, oncology continues to be a prominent area of interest, especially for targets linked to drug resistance, tumour progression, and difficult-to-treat malignancies.

Targeted Protein Degradation Market- Competitive Landscape:

With a wide range of players, including biotechnology firms, pharmaceutical companies, drug-discovery platform developers, academic research institutions, and specialized technology providers, the targeted protein degradation (TPD) market is fiercely competitive and growing quickly. Enhancing protein degraders' selectivity, potency, drug-like qualities, and therapeutic application is becoming a major focus of competition. The shift away from conventional PROTAC-based methods and toward a wider variety of degradation technologies is a significant industry trend. Molecular glues, LYTACs, degrader-antibody conjugates, and other proximity-based modalities are being developed by companies to target various protein classes and cellular compartments.

Recent Developments:

In September 2025, Arvinas and Pfizer announced plans to jointly identify a third-party partner for the out-licensing and commercialization of vepdegestrant, an oral PROTAC estrogen receptor degrader being developed for patients with ER+/HER2- advanced or metastatic breast cancer harboring ESR1 mutations.

In May 2025, C4 Therapeutics reported continued progress in the development of cemsidomide, an IKZF1/3 degrader, while also highlighting milestones under its collaboration with Roche focused on developing highly catalytic, orally bioavailable, and brain-penetrant targeted protein degraders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TARGETED PROTEIN DEGRADATION MARKET KEY PLAYERS

  • Arvinas, Inc.
  • Bristol Myers Squibb
  • C4 Therapeutics, Inc.
  • Kymera Therapeutics, Inc.
  • Nurix Therapeutics, Inc.
  • AstraZeneca plc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Bayer AG
  • Monte Rosa Therapeutics
  • Captor Therapeutics
  • Foghorn Therapeutics
  • Biotheryx, Inc.
  • Cullgen, Inc.
  • Others

GLOBAL TARGETED PROTEIN DEGRADATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033

  • PROTAC-based degraders
  • LYTACs
  • Molecular glue degraders
  • AUTOTACs
  • Others

GLOBAL TARGETED PROTEIN DEGRADATION MARKET, BY DEVELOPMENT STAGE- MARKET ANALYSIS, 2020-2033

  • Preclinical
  • Commercialized

GLOBAL TARGETED PROTEIN DEGRADATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Oncology
  • Hematological Malignancies
  • Autoimmune & Inflammatory Diseases
  • Cardiovascular Diseases
  • Others

GLOBAL TARGETED PROTEIN DEGRADATION MARKET, BY END USER- MARKET ANALYSIS, 2020-2033

  • Pharma & Biotech Companies
  • Academic Research
  • CROs
  • Hospitals
  • Others

GLOBAL TARGETED PROTEIN DEGRADATION MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Targeted Protein Degradation Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Targeted Protein Degradation Market Snippet by Product Type
    • 2.1.2. Targeted Protein Degradation Market Snippet by Development Stage
    • 2.1.3. Targeted Protein Degradation Market Snippet by Application
    • 2.1.4. Targeted Protein Degradation Market Snippet by End User
    • 2.1.5. Targeted Protein Degradation Market Snippet by Country
    • 2.1.6. Targeted Protein Degradation Market Snippet by Region
  • 2.2. Competitive Insights

3. Targeted Protein Degradation Key Market Trends

  • 3.1. Targeted Protein Degradation Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Targeted Protein Degradation Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Targeted Protein Degradation Market Opportunities
  • 3.4. Targeted Protein Degradation Market Future Trends

4. Targeted Protein Degradation Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Targeted Protein Degradation Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Targeted Protein Degradation Market Landscape

  • 6.1. Targeted Protein Degradation Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Targeted Protein Degradation Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. PROTAC-based degraders
    • 7.1.3. LYTACs
    • 7.1.4. Molecular glue degraders
    • 7.1.5. AUTOTACs
    • 7.1.6. Others

8. Targeted Protein Degradation Market - By Development Stage

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Development Stage, 2025 & 2033 (%)
    • 8.1.2. Preclinical
    • 8.1.3. Commercialized

9. Targeted Protein Degradation Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Oncology
    • 9.1.3. Haematological Malignancies
    • 9.1.4. Autoimmune & Inflammatory Diseases
    • 9.1.5. Cardiovascular Diseases
    • 9.1.6. Others

10. Targeted Protein Degradation Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. Pharma & Biotech Companies
    • 10.1.3. Academic Research
    • 10.1.4. CROs
    • 10.1.5. Hospitals
    • 10.1.6. Others

11. Targeted Protein Degradation Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Targeted Protein Degradation Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Targeted Protein Degradation Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Targeted Protein Degradation Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Targeted Protein Degradation Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Targeted Protein Degradation Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Development Stage, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Targeted Protein Degradation Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arvinas, Inc.
    • 12.2.2. Bristol Myers Squibb
    • 12.2.3. C4 Therapeutics, Inc.
    • 12.2.4. Kymera Therapeutics, Inc.
    • 12.2.5. Nurix Therapeutics, Inc.
    • 12.2.6. AstraZeneca plc
    • 12.2.7. Novartis AG
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Pfizer Inc.
    • 12.2.10. Bayer AG
    • 12.2.11. Monte Rosa Therapeutics
    • 12.2.12. Captor Therapeutics
    • 12.2.13. Foghorn Therapeutics
    • 12.2.14. Biotheryx, Inc.
    • 12.2.15. Cullgen, Inc.
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us